Analyze performance of private biotech investors

$ in millions; includes Series A-IPO deals from January 2018-present; includes investors with at least 5 announced deals; MOIC data includes some pre-2018 deals


Investor name Investor type Investor style Number of new investments since Jan-18 Number of lead investments since Jan-18 Number of exits since Jan-18 % of companies that IPO % of companies that are acquired % of companies that are "zombies" % of companies funded in last 2 years Weighted average cash-on-cash return (MOIC) of exits Number of deals where MOIC data is available Number of investments in top 5% of MOIC

This is a preview of our platform. Subscribe for full access.